Cite
HARVARD Citation
Manoff, S. et al. (2019). Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults. Human vaccines & immunotherapeutics. 15 (9), pp. 2195-2204. [Online].